nodes	percent_of_prediction	percent_of_DWPC	metapath
Fesoterodine—CYP3A4—type 2 diabetes mellitus	0.218	1	CbGaD
Fesoterodine—ABCB1—Linagliptin—type 2 diabetes mellitus	0.0492	0.104	CbGbCtD
Fesoterodine—ABCB1—Sitagliptin—type 2 diabetes mellitus	0.0438	0.0927	CbGbCtD
Fesoterodine—ABCB1—Chlorpropamide—type 2 diabetes mellitus	0.0317	0.067	CbGbCtD
Fesoterodine—CYP2D6—Pioglitazone—type 2 diabetes mellitus	0.0299	0.0632	CbGbCtD
Fesoterodine—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.0295	0.0623	CbGbCtD
Fesoterodine—CYP2D6—Rosiglitazone—type 2 diabetes mellitus	0.0275	0.0583	CbGbCtD
Fesoterodine—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.0263	0.0556	CbGbCtD
Fesoterodine—CYP3A4—Glipizide—type 2 diabetes mellitus	0.024	0.0508	CbGbCtD
Fesoterodine—CYP2D6—Nateglinide—type 2 diabetes mellitus	0.0226	0.0479	CbGbCtD
Fesoterodine—ABCB1—Bromocriptine—type 2 diabetes mellitus	0.0218	0.0461	CbGbCtD
Fesoterodine—CYP2D6—Irbesartan—type 2 diabetes mellitus	0.0217	0.0459	CbGbCtD
Fesoterodine—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.021	0.0444	CbGbCtD
Fesoterodine—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.019	0.0402	CbGbCtD
Fesoterodine—ABCB1—Glyburide—type 2 diabetes mellitus	0.0162	0.0343	CbGbCtD
Fesoterodine—ABCB1—Losartan—type 2 diabetes mellitus	0.0148	0.0314	CbGbCtD
Fesoterodine—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.0144	0.0304	CbGbCtD
Fesoterodine—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.0138	0.0292	CbGbCtD
Fesoterodine—CYP3A4—Orlistat—type 2 diabetes mellitus	0.0138	0.0292	CbGbCtD
Fesoterodine—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.013	0.0276	CbGbCtD
Fesoterodine—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00972	0.0206	CbGbCtD
Fesoterodine—CYP3A4—Losartan—type 2 diabetes mellitus	0.00889	0.0188	CbGbCtD
Fesoterodine—Vertigo—Orlistat—type 2 diabetes mellitus	0.000244	0.00113	CcSEcCtD
Fesoterodine—Gastrointestinal pain—Bromocriptine—type 2 diabetes mellitus	0.000243	0.00113	CcSEcCtD
Fesoterodine—Hypersensitivity—Glimepiride—type 2 diabetes mellitus	0.000243	0.00113	CcSEcCtD
Fesoterodine—Palpitations—Valsartan—type 2 diabetes mellitus	0.000243	0.00113	CcSEcCtD
Fesoterodine—Asthenia—Pioglitazone—type 2 diabetes mellitus	0.000243	0.00113	CcSEcCtD
Fesoterodine—Infection—Gliclazide—type 2 diabetes mellitus	0.000243	0.00113	CcSEcCtD
Fesoterodine—Hypersensitivity—Sitagliptin—type 2 diabetes mellitus	0.000242	0.00112	CcSEcCtD
Fesoterodine—Diarrhoea—Glipizide—type 2 diabetes mellitus	0.000242	0.00112	CcSEcCtD
Fesoterodine—Palpitations—Orlistat—type 2 diabetes mellitus	0.00024	0.00111	CcSEcCtD
Fesoterodine—Cough—Valsartan—type 2 diabetes mellitus	0.00024	0.00111	CcSEcCtD
Fesoterodine—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.00024	0.00111	CcSEcCtD
Fesoterodine—Nervous system disorder—Gliclazide—type 2 diabetes mellitus	0.000239	0.00111	CcSEcCtD
Fesoterodine—Dyspepsia—Glyburide—type 2 diabetes mellitus	0.000239	0.00111	CcSEcCtD
Fesoterodine—Tachycardia—Gliclazide—type 2 diabetes mellitus	0.000238	0.00111	CcSEcCtD
Fesoterodine—Skin disorder—Gliclazide—type 2 diabetes mellitus	0.000237	0.0011	CcSEcCtD
Fesoterodine—Urinary tract infection—Ramipril—type 2 diabetes mellitus	0.000237	0.0011	CcSEcCtD
Fesoterodine—Cough—Orlistat—type 2 diabetes mellitus	0.000237	0.0011	CcSEcCtD
Fesoterodine—Asthenia—Glimepiride—type 2 diabetes mellitus	0.000237	0.0011	CcSEcCtD
Fesoterodine—Urticaria—Bromocriptine—type 2 diabetes mellitus	0.000236	0.0011	CcSEcCtD
Fesoterodine—Vision blurred—Metformin—type 2 diabetes mellitus	0.000236	0.0011	CcSEcCtD
Fesoterodine—Asthenia—Sitagliptin—type 2 diabetes mellitus	0.000236	0.00109	CcSEcCtD
Fesoterodine—Abdominal pain—Bromocriptine—type 2 diabetes mellitus	0.000235	0.00109	CcSEcCtD
Fesoterodine—Gastrointestinal disorder—Glyburide—type 2 diabetes mellitus	0.000235	0.00109	CcSEcCtD
Fesoterodine—Chest pain—Valsartan—type 2 diabetes mellitus	0.000234	0.00109	CcSEcCtD
Fesoterodine—Dizziness—Glipizide—type 2 diabetes mellitus	0.000234	0.00108	CcSEcCtD
Fesoterodine—Pruritus—Glimepiride—type 2 diabetes mellitus	0.000233	0.00108	CcSEcCtD
Fesoterodine—Flatulence—Irbesartan—type 2 diabetes mellitus	0.000233	0.00108	CcSEcCtD
Fesoterodine—Unspecified disorder of skin and subcutaneous tissue—Valsartan—type 2 diabetes mellitus	0.000232	0.00108	CcSEcCtD
Fesoterodine—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.000232	0.00108	CcSEcCtD
Fesoterodine—Dysgeusia—Irbesartan—type 2 diabetes mellitus	0.000231	0.00107	CcSEcCtD
Fesoterodine—Chest pain—Orlistat—type 2 diabetes mellitus	0.000231	0.00107	CcSEcCtD
Fesoterodine—Hepatobiliary disease—Ramipril—type 2 diabetes mellitus	0.000231	0.00107	CcSEcCtD
Fesoterodine—Unspecified disorder of skin and subcutaneous tissue—Orlistat—type 2 diabetes mellitus	0.00023	0.00107	CcSEcCtD
Fesoterodine—Dry mouth—Valsartan—type 2 diabetes mellitus	0.000229	0.00106	CcSEcCtD
Fesoterodine—Dry mouth—Orlistat—type 2 diabetes mellitus	0.000226	0.00105	CcSEcCtD
Fesoterodine—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.000226	0.00105	CcSEcCtD
Fesoterodine—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.000225	0.00104	CcSEcCtD
Fesoterodine—Feeling abnormal—Glyburide—type 2 diabetes mellitus	0.000224	0.00104	CcSEcCtD
Fesoterodine—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000224	0.00104	CcSEcCtD
Fesoterodine—Infection—Valsartan—type 2 diabetes mellitus	0.000223	0.00103	CcSEcCtD
Fesoterodine—Rash—Glipizide—type 2 diabetes mellitus	0.000223	0.00103	CcSEcCtD
Fesoterodine—Vision blurred—Irbesartan—type 2 diabetes mellitus	0.000223	0.00103	CcSEcCtD
Fesoterodine—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000223	0.00103	CcSEcCtD
Fesoterodine—Gastrointestinal pain—Glyburide—type 2 diabetes mellitus	0.000222	0.00103	CcSEcCtD
Fesoterodine—Headache—Glipizide—type 2 diabetes mellitus	0.000221	0.00103	CcSEcCtD
Fesoterodine—Palpitations—Metformin—type 2 diabetes mellitus	0.000221	0.00103	CcSEcCtD
Fesoterodine—Insomnia—Gliclazide—type 2 diabetes mellitus	0.000221	0.00103	CcSEcCtD
Fesoterodine—Infection—Orlistat—type 2 diabetes mellitus	0.00022	0.00102	CcSEcCtD
Fesoterodine—Nervous system disorder—Valsartan—type 2 diabetes mellitus	0.00022	0.00102	CcSEcCtD
Fesoterodine—Flatulence—Losartan—type 2 diabetes mellitus	0.000219	0.00102	CcSEcCtD
Fesoterodine—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000218	0.00101	CcSEcCtD
Fesoterodine—Skin disorder—Valsartan—type 2 diabetes mellitus	0.000218	0.00101	CcSEcCtD
Fesoterodine—Dysgeusia—Losartan—type 2 diabetes mellitus	0.000218	0.00101	CcSEcCtD
Fesoterodine—Nervous system disorder—Orlistat—type 2 diabetes mellitus	0.000217	0.00101	CcSEcCtD
Fesoterodine—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000217	0.00101	CcSEcCtD
Fesoterodine—Somnolence—Gliclazide—type 2 diabetes mellitus	0.000217	0.00101	CcSEcCtD
Fesoterodine—Urticaria—Glyburide—type 2 diabetes mellitus	0.000216	0.001	CcSEcCtD
Fesoterodine—Angioedema—Irbesartan—type 2 diabetes mellitus	0.000216	0.001	CcSEcCtD
Fesoterodine—Oedema peripheral—Ramipril—type 2 diabetes mellitus	0.000216	0.001	CcSEcCtD
Fesoterodine—Skin disorder—Orlistat—type 2 diabetes mellitus	0.000215	0.001	CcSEcCtD
Fesoterodine—Back pain—Losartan—type 2 diabetes mellitus	0.000215	0.000998	CcSEcCtD
Fesoterodine—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.000215	0.000998	CcSEcCtD
Fesoterodine—Dyspepsia—Gliclazide—type 2 diabetes mellitus	0.000215	0.000998	CcSEcCtD
Fesoterodine—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000213	0.000991	CcSEcCtD
Fesoterodine—Chest pain—Metformin—type 2 diabetes mellitus	0.000213	0.000989	CcSEcCtD
Fesoterodine—Vertigo—Irbesartan—type 2 diabetes mellitus	0.000212	0.000985	CcSEcCtD
Fesoterodine—Headache—Pioglitazone—type 2 diabetes mellitus	0.000212	0.000984	CcSEcCtD
Fesoterodine—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	0.000212	0.000982	CcSEcCtD
Fesoterodine—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.000211	0.000979	CcSEcCtD
Fesoterodine—Fatigue—Gliclazide—type 2 diabetes mellitus	0.000211	0.000977	CcSEcCtD
Fesoterodine—Nausea—Glipizide—type 2 diabetes mellitus	0.00021	0.000974	CcSEcCtD
Fesoterodine—Vision blurred—Losartan—type 2 diabetes mellitus	0.00021	0.000973	CcSEcCtD
Fesoterodine—Constipation—Gliclazide—type 2 diabetes mellitus	0.000209	0.000969	CcSEcCtD
Fesoterodine—Rash—Glimepiride—type 2 diabetes mellitus	0.000208	0.000965	CcSEcCtD
Fesoterodine—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000208	0.000964	CcSEcCtD
Fesoterodine—Rash—Sitagliptin—type 2 diabetes mellitus	0.000207	0.000962	CcSEcCtD
Fesoterodine—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000207	0.000961	CcSEcCtD
Fesoterodine—Headache—Glimepiride—type 2 diabetes mellitus	0.000207	0.000959	CcSEcCtD
Fesoterodine—Cough—Irbesartan—type 2 diabetes mellitus	0.000206	0.000957	CcSEcCtD
Fesoterodine—Headache—Sitagliptin—type 2 diabetes mellitus	0.000206	0.000956	CcSEcCtD
Fesoterodine—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000204	0.000945	CcSEcCtD
Fesoterodine—Angioedema—Losartan—type 2 diabetes mellitus	0.000203	0.000943	CcSEcCtD
Fesoterodine—Infection—Metformin—type 2 diabetes mellitus	0.000203	0.000942	CcSEcCtD
Fesoterodine—Insomnia—Valsartan—type 2 diabetes mellitus	0.000203	0.000942	CcSEcCtD
Fesoterodine—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.000201	0.000934	CcSEcCtD
Fesoterodine—Chest pain—Irbesartan—type 2 diabetes mellitus	0.000201	0.000934	CcSEcCtD
Fesoterodine—Insomnia—Orlistat—type 2 diabetes mellitus	0.0002	0.000931	CcSEcCtD
Fesoterodine—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.0002	0.00093	CcSEcCtD
Fesoterodine—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.0002	0.00093	CcSEcCtD
Fesoterodine—Vertigo—Losartan—type 2 diabetes mellitus	0.0002	0.000927	CcSEcCtD
Fesoterodine—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.0002	0.000927	CcSEcCtD
Fesoterodine—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.0002	0.000927	CcSEcCtD
Fesoterodine—Somnolence—Valsartan—type 2 diabetes mellitus	0.000199	0.000926	CcSEcCtD
Fesoterodine—Skin disorder—Metformin—type 2 diabetes mellitus	0.000198	0.000921	CcSEcCtD
Fesoterodine—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.000197	0.000917	CcSEcCtD
Fesoterodine—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	0.000197	0.000916	CcSEcCtD
Fesoterodine—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000197	0.000913	CcSEcCtD
Fesoterodine—Dry mouth—Irbesartan—type 2 diabetes mellitus	0.000197	0.000913	CcSEcCtD
Fesoterodine—Palpitations—Losartan—type 2 diabetes mellitus	0.000196	0.000912	CcSEcCtD
Fesoterodine—Nausea—Glimepiride—type 2 diabetes mellitus	0.000196	0.000909	CcSEcCtD
Fesoterodine—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000195	0.000906	CcSEcCtD
Fesoterodine—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.000195	0.000906	CcSEcCtD
Fesoterodine—Asthenia—Glyburide—type 2 diabetes mellitus	0.000195	0.000906	CcSEcCtD
Fesoterodine—Cough—Losartan—type 2 diabetes mellitus	0.000194	0.000901	CcSEcCtD
Fesoterodine—Urticaria—Gliclazide—type 2 diabetes mellitus	0.000194	0.0009	CcSEcCtD
Fesoterodine—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000194	0.000899	CcSEcCtD
Fesoterodine—Fatigue—Valsartan—type 2 diabetes mellitus	0.000193	0.000898	CcSEcCtD
Fesoterodine—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000193	0.000896	CcSEcCtD
Fesoterodine—Pruritus—Glyburide—type 2 diabetes mellitus	0.000192	0.000893	CcSEcCtD
Fesoterodine—Mental disorder—Ramipril—type 2 diabetes mellitus	0.000192	0.000891	CcSEcCtD
Fesoterodine—Constipation—Valsartan—type 2 diabetes mellitus	0.000192	0.000891	CcSEcCtD
Fesoterodine—Infection—Irbesartan—type 2 diabetes mellitus	0.000192	0.000889	CcSEcCtD
Fesoterodine—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.000191	0.000888	CcSEcCtD
Fesoterodine—Fatigue—Orlistat—type 2 diabetes mellitus	0.000191	0.000887	CcSEcCtD
Fesoterodine—Chest pain—Losartan—type 2 diabetes mellitus	0.000189	0.000879	CcSEcCtD
Fesoterodine—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.000189	0.000878	CcSEcCtD
Fesoterodine—Tachycardia—Irbesartan—type 2 diabetes mellitus	0.000188	0.000873	CcSEcCtD
Fesoterodine—Rash—Bromocriptine—type 2 diabetes mellitus	0.000188	0.000871	CcSEcCtD
Fesoterodine—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000187	0.00087	CcSEcCtD
Fesoterodine—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.000187	0.000869	CcSEcCtD
Fesoterodine—Dysgeusia—Ramipril—type 2 diabetes mellitus	0.000187	0.000867	CcSEcCtD
Fesoterodine—Headache—Bromocriptine—type 2 diabetes mellitus	0.000186	0.000865	CcSEcCtD
Fesoterodine—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000186	0.000864	CcSEcCtD
Fesoterodine—Dry mouth—Losartan—type 2 diabetes mellitus	0.000185	0.000859	CcSEcCtD
Fesoterodine—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.000183	0.000852	CcSEcCtD
Fesoterodine—Confusional state—Losartan—type 2 diabetes mellitus	0.000183	0.000849	CcSEcCtD
Fesoterodine—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.000183	0.000848	CcSEcCtD
Fesoterodine—Somnolence—Metformin—type 2 diabetes mellitus	0.000182	0.000843	CcSEcCtD
Fesoterodine—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.000181	0.000841	CcSEcCtD
Fesoterodine—Infection—Losartan—type 2 diabetes mellitus	0.00018	0.000837	CcSEcCtD
Fesoterodine—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.00018	0.000835	CcSEcCtD
Fesoterodine—Dyspepsia—Metformin—type 2 diabetes mellitus	0.00018	0.000835	CcSEcCtD
Fesoterodine—Urticaria—Valsartan—type 2 diabetes mellitus	0.000178	0.000827	CcSEcCtD
Fesoterodine—Nervous system disorder—Losartan—type 2 diabetes mellitus	0.000178	0.000826	CcSEcCtD
Fesoterodine—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.000177	0.000823	CcSEcCtD
Fesoterodine—Tachycardia—Losartan—type 2 diabetes mellitus	0.000177	0.000822	CcSEcCtD
Fesoterodine—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000177	0.00082	CcSEcCtD
Fesoterodine—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.000176	0.000819	CcSEcCtD
Fesoterodine—Fatigue—Metformin—type 2 diabetes mellitus	0.000176	0.000818	CcSEcCtD
Fesoterodine—Urticaria—Orlistat—type 2 diabetes mellitus	0.000176	0.000817	CcSEcCtD
Fesoterodine—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.000175	0.000813	CcSEcCtD
Fesoterodine—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000175	0.000813	CcSEcCtD
Fesoterodine—Constipation—Metformin—type 2 diabetes mellitus	0.000175	0.000811	CcSEcCtD
Fesoterodine—Angioedema—Ramipril—type 2 diabetes mellitus	0.000174	0.000809	CcSEcCtD
Fesoterodine—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000173	0.000802	CcSEcCtD
Fesoterodine—Rash—Glyburide—type 2 diabetes mellitus	0.000171	0.000796	CcSEcCtD
Fesoterodine—Somnolence—Irbesartan—type 2 diabetes mellitus	0.000171	0.000796	CcSEcCtD
Fesoterodine—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000171	0.000795	CcSEcCtD
Fesoterodine—Vertigo—Ramipril—type 2 diabetes mellitus	0.000171	0.000795	CcSEcCtD
Fesoterodine—Headache—Glyburide—type 2 diabetes mellitus	0.00017	0.000791	CcSEcCtD
Fesoterodine—Dyspepsia—Irbesartan—type 2 diabetes mellitus	0.00017	0.000788	CcSEcCtD
Fesoterodine—Disopyramide—CYP3A4—type 2 diabetes mellitus	0.000169	0.5	CrCbGaD
Fesoterodine—Tolterodine—CYP3A4—type 2 diabetes mellitus	0.000169	0.5	CrCbGaD
Fesoterodine—Palpitations—Ramipril—type 2 diabetes mellitus	0.000168	0.000782	CcSEcCtD
Fesoterodine—Feeling abnormal—Metformin—type 2 diabetes mellitus	0.000168	0.000781	CcSEcCtD
Fesoterodine—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000167	0.000776	CcSEcCtD
Fesoterodine—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.000167	0.000775	CcSEcCtD
Fesoterodine—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.000166	0.000773	CcSEcCtD
Fesoterodine—Cough—Ramipril—type 2 diabetes mellitus	0.000166	0.000772	CcSEcCtD
Fesoterodine—Fatigue—Irbesartan—type 2 diabetes mellitus	0.000166	0.000772	CcSEcCtD
Fesoterodine—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.000165	0.000767	CcSEcCtD
Fesoterodine—Constipation—Irbesartan—type 2 diabetes mellitus	0.000165	0.000765	CcSEcCtD
Fesoterodine—Insomnia—Losartan—type 2 diabetes mellitus	0.000164	0.000762	CcSEcCtD
Fesoterodine—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000163	0.000758	CcSEcCtD
Fesoterodine—Urticaria—Metformin—type 2 diabetes mellitus	0.000162	0.000753	CcSEcCtD
Fesoterodine—Chest pain—Ramipril—type 2 diabetes mellitus	0.000162	0.000753	CcSEcCtD
Fesoterodine—Nausea—Glyburide—type 2 diabetes mellitus	0.000162	0.00075	CcSEcCtD
Fesoterodine—Abdominal pain—Metformin—type 2 diabetes mellitus	0.000161	0.00075	CcSEcCtD
Fesoterodine—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000161	0.00075	CcSEcCtD
Fesoterodine—Somnolence—Losartan—type 2 diabetes mellitus	0.000161	0.000749	CcSEcCtD
Fesoterodine—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	0.000161	0.000748	CcSEcCtD
Fesoterodine—Asthenia—Valsartan—type 2 diabetes mellitus	0.000161	0.000747	CcSEcCtD
Fesoterodine—Dyspepsia—Losartan—type 2 diabetes mellitus	0.00016	0.000741	CcSEcCtD
Fesoterodine—Asthenia—Orlistat—type 2 diabetes mellitus	0.000159	0.000738	CcSEcCtD
Fesoterodine—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	0.000159	0.000737	CcSEcCtD
Fesoterodine—Pruritus—Valsartan—type 2 diabetes mellitus	0.000159	0.000737	CcSEcCtD
Fesoterodine—Dry mouth—Ramipril—type 2 diabetes mellitus	0.000159	0.000737	CcSEcCtD
Fesoterodine—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	0.000158	0.000732	CcSEcCtD
Fesoterodine—Confusional state—Ramipril—type 2 diabetes mellitus	0.000157	0.000728	CcSEcCtD
Fesoterodine—Pruritus—Orlistat—type 2 diabetes mellitus	0.000157	0.000728	CcSEcCtD
Fesoterodine—Fatigue—Losartan—type 2 diabetes mellitus	0.000156	0.000726	CcSEcCtD
Fesoterodine—Constipation—Losartan—type 2 diabetes mellitus	0.000155	0.00072	CcSEcCtD
Fesoterodine—Rash—Gliclazide—type 2 diabetes mellitus	0.000154	0.000715	CcSEcCtD
Fesoterodine—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000154	0.000714	CcSEcCtD
Fesoterodine—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000153	0.000713	CcSEcCtD
Fesoterodine—Urticaria—Irbesartan—type 2 diabetes mellitus	0.000153	0.000711	CcSEcCtD
Fesoterodine—Headache—Gliclazide—type 2 diabetes mellitus	0.000153	0.00071	CcSEcCtD
Fesoterodine—Nervous system disorder—Ramipril—type 2 diabetes mellitus	0.000153	0.000708	CcSEcCtD
Fesoterodine—Abdominal pain—Irbesartan—type 2 diabetes mellitus	0.000152	0.000707	CcSEcCtD
Fesoterodine—Tachycardia—Ramipril—type 2 diabetes mellitus	0.000152	0.000705	CcSEcCtD
Fesoterodine—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000152	0.000704	CcSEcCtD
Fesoterodine—Skin disorder—Ramipril—type 2 diabetes mellitus	0.000151	0.000701	CcSEcCtD
Fesoterodine—Feeling abnormal—Losartan—type 2 diabetes mellitus	0.00015	0.000694	CcSEcCtD
Fesoterodine—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	0.000148	0.000689	CcSEcCtD
Fesoterodine—Dizziness—Valsartan—type 2 diabetes mellitus	0.000148	0.000689	CcSEcCtD
Fesoterodine—Dizziness—Orlistat—type 2 diabetes mellitus	0.000147	0.00068	CcSEcCtD
Fesoterodine—Asthenia—Metformin—type 2 diabetes mellitus	0.000147	0.00068	CcSEcCtD
Fesoterodine—Nausea—Gliclazide—type 2 diabetes mellitus	0.000145	0.000673	CcSEcCtD
Fesoterodine—Pruritus—Metformin—type 2 diabetes mellitus	0.000145	0.000671	CcSEcCtD
Fesoterodine—Urticaria—Losartan—type 2 diabetes mellitus	0.000144	0.000669	CcSEcCtD
Fesoterodine—Abdominal pain—Losartan—type 2 diabetes mellitus	0.000143	0.000666	CcSEcCtD
Fesoterodine—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.000142	0.000659	CcSEcCtD
Fesoterodine—Rash—Valsartan—type 2 diabetes mellitus	0.000141	0.000657	CcSEcCtD
Fesoterodine—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000141	0.000656	CcSEcCtD
Fesoterodine—Insomnia—Ramipril—type 2 diabetes mellitus	0.000141	0.000653	CcSEcCtD
Fesoterodine—Headache—Valsartan—type 2 diabetes mellitus	0.000141	0.000652	CcSEcCtD
Fesoterodine—Diarrhoea—Metformin—type 2 diabetes mellitus	0.00014	0.000649	CcSEcCtD
Fesoterodine—Rash—Orlistat—type 2 diabetes mellitus	0.00014	0.000649	CcSEcCtD
Fesoterodine—Dermatitis—Orlistat—type 2 diabetes mellitus	0.00014	0.000648	CcSEcCtD
Fesoterodine—Headache—Orlistat—type 2 diabetes mellitus	0.000139	0.000645	CcSEcCtD
Fesoterodine—Asthenia—Irbesartan—type 2 diabetes mellitus	0.000138	0.000642	CcSEcCtD
Fesoterodine—Somnolence—Ramipril—type 2 diabetes mellitus	0.000138	0.000642	CcSEcCtD
Fesoterodine—Dyspepsia—Ramipril—type 2 diabetes mellitus	0.000137	0.000636	CcSEcCtD
Fesoterodine—Pruritus—Irbesartan—type 2 diabetes mellitus	0.000136	0.000633	CcSEcCtD
Fesoterodine—Dizziness—Metformin—type 2 diabetes mellitus	0.000135	0.000627	CcSEcCtD
Fesoterodine—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	0.000134	0.000623	CcSEcCtD
Fesoterodine—Fatigue—Ramipril—type 2 diabetes mellitus	0.000134	0.000623	CcSEcCtD
Fesoterodine—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.000134	0.000621	CcSEcCtD
Fesoterodine—Nausea—Valsartan—type 2 diabetes mellitus	0.000133	0.000619	CcSEcCtD
Fesoterodine—Constipation—Ramipril—type 2 diabetes mellitus	0.000133	0.000618	CcSEcCtD
Fesoterodine—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.000132	0.000612	CcSEcCtD
Fesoterodine—Nausea—Orlistat—type 2 diabetes mellitus	0.000132	0.000611	CcSEcCtD
Fesoterodine—Asthenia—Losartan—type 2 diabetes mellitus	0.00013	0.000604	CcSEcCtD
Fesoterodine—Rash—Metformin—type 2 diabetes mellitus	0.000129	0.000598	CcSEcCtD
Fesoterodine—Dermatitis—Metformin—type 2 diabetes mellitus	0.000129	0.000597	CcSEcCtD
Fesoterodine—Pruritus—Losartan—type 2 diabetes mellitus	0.000128	0.000596	CcSEcCtD
Fesoterodine—Feeling abnormal—Ramipril—type 2 diabetes mellitus	0.000128	0.000595	CcSEcCtD
Fesoterodine—Headache—Metformin—type 2 diabetes mellitus	0.000128	0.000594	CcSEcCtD
Fesoterodine—Dizziness—Irbesartan—type 2 diabetes mellitus	0.000127	0.000592	CcSEcCtD
Fesoterodine—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	0.000127	0.000591	CcSEcCtD
Fesoterodine—Diarrhoea—Losartan—type 2 diabetes mellitus	0.000124	0.000576	CcSEcCtD
Fesoterodine—Urticaria—Ramipril—type 2 diabetes mellitus	0.000124	0.000574	CcSEcCtD
Fesoterodine—Abdominal pain—Ramipril—type 2 diabetes mellitus	0.000123	0.000571	CcSEcCtD
Fesoterodine—Rash—Irbesartan—type 2 diabetes mellitus	0.000122	0.000564	CcSEcCtD
Fesoterodine—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000121	0.000564	CcSEcCtD
Fesoterodine—Nausea—Metformin—type 2 diabetes mellitus	0.000121	0.000563	CcSEcCtD
Fesoterodine—Headache—Irbesartan—type 2 diabetes mellitus	0.000121	0.000561	CcSEcCtD
Fesoterodine—Dizziness—Losartan—type 2 diabetes mellitus	0.00012	0.000557	CcSEcCtD
Fesoterodine—Hypersensitivity—Ramipril—type 2 diabetes mellitus	0.000115	0.000532	CcSEcCtD
Fesoterodine—Nausea—Irbesartan—type 2 diabetes mellitus	0.000115	0.000532	CcSEcCtD
Fesoterodine—Rash—Losartan—type 2 diabetes mellitus	0.000114	0.000531	CcSEcCtD
Fesoterodine—Dermatitis—Losartan—type 2 diabetes mellitus	0.000114	0.000531	CcSEcCtD
Fesoterodine—Headache—Losartan—type 2 diabetes mellitus	0.000114	0.000528	CcSEcCtD
Fesoterodine—Asthenia—Ramipril—type 2 diabetes mellitus	0.000112	0.000518	CcSEcCtD
Fesoterodine—Pruritus—Ramipril—type 2 diabetes mellitus	0.00011	0.000511	CcSEcCtD
Fesoterodine—Nausea—Losartan—type 2 diabetes mellitus	0.000108	0.0005	CcSEcCtD
Fesoterodine—Diarrhoea—Ramipril—type 2 diabetes mellitus	0.000106	0.000494	CcSEcCtD
Fesoterodine—Dizziness—Ramipril—type 2 diabetes mellitus	0.000103	0.000478	CcSEcCtD
Fesoterodine—Rash—Ramipril—type 2 diabetes mellitus	9.81e-05	0.000455	CcSEcCtD
Fesoterodine—Dermatitis—Ramipril—type 2 diabetes mellitus	9.8e-05	0.000455	CcSEcCtD
Fesoterodine—Headache—Ramipril—type 2 diabetes mellitus	9.75e-05	0.000452	CcSEcCtD
Fesoterodine—Nausea—Ramipril—type 2 diabetes mellitus	9.24e-05	0.000429	CcSEcCtD
Fesoterodine—ABCB1—Metabolism—CYP3A4—type 2 diabetes mellitus	7.6e-06	8.14e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—ADCY5—type 2 diabetes mellitus	7.58e-06	8.12e-05	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling by GPCR—EGFR—type 2 diabetes mellitus	7.58e-06	8.12e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—ADCY5—type 2 diabetes mellitus	7.56e-06	8.1e-05	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	7.56e-06	8.09e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—ADCY5—type 2 diabetes mellitus	7.49e-06	8.02e-05	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—GCG—type 2 diabetes mellitus	7.47e-06	8e-05	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—SLC2A4—type 2 diabetes mellitus	7.47e-06	8e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	7.45e-06	7.98e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	7.45e-06	7.98e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	7.45e-06	7.98e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	7.45e-06	7.98e-05	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—CYP2E1—type 2 diabetes mellitus	7.42e-06	7.95e-05	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—CYP1A2—type 2 diabetes mellitus	7.34e-06	7.86e-05	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—SLC2A1—type 2 diabetes mellitus	7.34e-06	7.86e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	7.27e-06	7.79e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	7.25e-06	7.76e-05	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	7.24e-06	7.75e-05	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	7.22e-06	7.73e-05	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—NOS3—type 2 diabetes mellitus	7.22e-06	7.73e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	7.18e-06	7.69e-05	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—CYP3A4—type 2 diabetes mellitus	7.16e-06	7.67e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	7.14e-06	7.65e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—CCR5—type 2 diabetes mellitus	7.14e-06	7.65e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—CCR5—type 2 diabetes mellitus	7.12e-06	7.62e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—CCR5—type 2 diabetes mellitus	7.05e-06	7.55e-05	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—GCG—type 2 diabetes mellitus	7.04e-06	7.54e-05	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—SLC2A4—type 2 diabetes mellitus	7.04e-06	7.54e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—C3—type 2 diabetes mellitus	6.98e-06	7.47e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—C3—type 2 diabetes mellitus	6.95e-06	7.45e-05	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—NOS3—type 2 diabetes mellitus	6.91e-06	7.4e-05	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	6.91e-06	7.4e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—C3—type 2 diabetes mellitus	6.89e-06	7.38e-05	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—RELA—type 2 diabetes mellitus	6.79e-06	7.27e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—PPARG—type 2 diabetes mellitus	6.74e-06	7.22e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—HIF1A—type 2 diabetes mellitus	6.65e-06	7.13e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	6.64e-06	7.11e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—IRS2—type 2 diabetes mellitus	6.64e-06	7.11e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—HIF1A—type 2 diabetes mellitus	6.63e-06	7.1e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—AGT—type 2 diabetes mellitus	6.63e-06	7.1e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—IRS2—type 2 diabetes mellitus	6.62e-06	7.09e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—INS—type 2 diabetes mellitus	6.61e-06	7.08e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—AGT—type 2 diabetes mellitus	6.61e-06	7.08e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—HIF1A—type 2 diabetes mellitus	6.57e-06	7.03e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—IRS2—type 2 diabetes mellitus	6.55e-06	7.02e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—AGT—type 2 diabetes mellitus	6.54e-06	7.01e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—CALM1—type 2 diabetes mellitus	6.52e-06	6.98e-05	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—RELA—type 2 diabetes mellitus	6.5e-06	6.97e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—CALM1—type 2 diabetes mellitus	6.5e-06	6.96e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—APOE—type 2 diabetes mellitus	6.49e-06	6.96e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—LEP—type 2 diabetes mellitus	6.49e-06	6.96e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—APOE—type 2 diabetes mellitus	6.47e-06	6.93e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—LEP—type 2 diabetes mellitus	6.47e-06	6.93e-05	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—PPARGC1A—type 2 diabetes mellitus	6.44e-06	6.89e-05	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—GNB3—type 2 diabetes mellitus	6.44e-06	6.89e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—CALM1—type 2 diabetes mellitus	6.43e-06	6.89e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—APOA1—type 2 diabetes mellitus	6.42e-06	6.88e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—LEP—type 2 diabetes mellitus	6.41e-06	6.87e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—APOE—type 2 diabetes mellitus	6.41e-06	6.87e-05	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—HMOX1—type 2 diabetes mellitus	6.41e-06	6.86e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—APOA1—type 2 diabetes mellitus	6.4e-06	6.85e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—APOA1—type 2 diabetes mellitus	6.34e-06	6.79e-05	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—CAT—type 2 diabetes mellitus	6.32e-06	6.77e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	6.2e-06	6.64e-05	CbGpPWpGaD
Fesoterodine—CHRM4—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	6.18e-06	6.62e-05	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—APOB—type 2 diabetes mellitus	6.14e-06	6.57e-05	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—CASP3—type 2 diabetes mellitus	6.13e-06	6.56e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	6.12e-06	6.56e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—PRKCB—type 2 diabetes mellitus	6.1e-06	6.54e-05	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling by GPCR—IL6—type 2 diabetes mellitus	6.09e-06	6.52e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	6.07e-06	6.5e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	6.07e-06	6.5e-05	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—GNB3—type 2 diabetes mellitus	6.07e-06	6.5e-05	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—PPARGC1A—type 2 diabetes mellitus	6.07e-06	6.5e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—ALB—type 2 diabetes mellitus	6.06e-06	6.49e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—PRKCB—type 2 diabetes mellitus	6.05e-06	6.48e-05	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—HMOX1—type 2 diabetes mellitus	6.04e-06	6.47e-05	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—GSTM1—type 2 diabetes mellitus	5.97e-06	6.39e-05	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—CAT—type 2 diabetes mellitus	5.96e-06	6.38e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	5.95e-06	6.38e-05	CbGpPWpGaD
Fesoterodine—CHRM5—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	5.92e-06	6.34e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	5.92e-06	6.34e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	5.92e-06	6.34e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	5.92e-06	6.34e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	5.88e-06	6.3e-05	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—CASP3—type 2 diabetes mellitus	5.87e-06	6.28e-05	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—LPL—type 2 diabetes mellitus	5.86e-06	6.28e-05	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling by GPCR—IL6—type 2 diabetes mellitus	5.83e-06	6.24e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—NOS3—type 2 diabetes mellitus	5.8e-06	6.21e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—PIK3R1—type 2 diabetes mellitus	5.8e-06	6.21e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—IRS1—type 2 diabetes mellitus	5.79e-06	6.21e-05	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—MMP9—type 2 diabetes mellitus	5.79e-06	6.2e-05	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—APOB—type 2 diabetes mellitus	5.78e-06	6.19e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	5.78e-06	6.19e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—IRS1—type 2 diabetes mellitus	5.78e-06	6.19e-05	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—ADCY5—type 2 diabetes mellitus	5.74e-06	6.15e-05	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—NFKB1—type 2 diabetes mellitus	5.73e-06	6.13e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—IRS1—type 2 diabetes mellitus	5.72e-06	6.13e-05	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—GPX1—type 2 diabetes mellitus	5.72e-06	6.12e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	5.71e-06	6.11e-05	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—GSTM1—type 2 diabetes mellitus	5.63e-06	6.03e-05	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling by GPCR—AKT1—type 2 diabetes mellitus	5.61e-06	6.01e-05	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—CD36—type 2 diabetes mellitus	5.57e-06	5.96e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—INS—type 2 diabetes mellitus	5.55e-06	5.94e-05	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—MMP9—type 2 diabetes mellitus	5.54e-06	5.94e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—INS—type 2 diabetes mellitus	5.53e-06	5.92e-05	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—LPL—type 2 diabetes mellitus	5.52e-06	5.92e-05	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—PPP2CA—type 2 diabetes mellitus	5.5e-06	5.89e-05	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—NFKB1—type 2 diabetes mellitus	5.49e-06	5.87e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—INS—type 2 diabetes mellitus	5.48e-06	5.87e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—CCL2—type 2 diabetes mellitus	5.46e-06	5.85e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—CCL2—type 2 diabetes mellitus	5.44e-06	5.83e-05	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—ADCY5—type 2 diabetes mellitus	5.41e-06	5.79e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—CCL2—type 2 diabetes mellitus	5.39e-06	5.77e-05	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—GPX1—type 2 diabetes mellitus	5.39e-06	5.77e-05	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling by GPCR—AKT1—type 2 diabetes mellitus	5.38e-06	5.76e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—IGF1—type 2 diabetes mellitus	5.37e-06	5.75e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—AKT2—type 2 diabetes mellitus	5.36e-06	5.74e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—IGF1—type 2 diabetes mellitus	5.35e-06	5.73e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—AKT2—type 2 diabetes mellitus	5.35e-06	5.73e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	5.34e-06	5.72e-05	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—SRC—type 2 diabetes mellitus	5.34e-06	5.72e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling by GPCR—EGFR—type 2 diabetes mellitus	5.32e-06	5.7e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	5.31e-06	5.68e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	5.31e-06	5.68e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	5.31e-06	5.68e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—PTGS2—type 2 diabetes mellitus	5.3e-06	5.68e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—IGF1—type 2 diabetes mellitus	5.3e-06	5.67e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—AKT2—type 2 diabetes mellitus	5.29e-06	5.67e-05	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—MTHFR—type 2 diabetes mellitus	5.28e-06	5.65e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling by GPCR—EGFR—type 2 diabetes mellitus	5.27e-06	5.65e-05	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—CD36—type 2 diabetes mellitus	5.25e-06	5.62e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	5.21e-06	5.58e-05	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—VEGFA—type 2 diabetes mellitus	5.2e-06	5.57e-05	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—PPP2CA—type 2 diabetes mellitus	5.18e-06	5.55e-05	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—PPARA—type 2 diabetes mellitus	5.18e-06	5.54e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	5.16e-06	5.53e-05	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—SRC—type 2 diabetes mellitus	5.11e-06	5.47e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	5.1e-06	5.46e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	5.08e-06	5.44e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	5.05e-06	5.41e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	5.03e-06	5.39e-05	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—AGT—type 2 diabetes mellitus	5.01e-06	5.37e-05	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—VEGFA—type 2 diabetes mellitus	4.98e-06	5.33e-05	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—MTHFR—type 2 diabetes mellitus	4.97e-06	5.33e-05	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—CALM1—type 2 diabetes mellitus	4.93e-06	5.28e-05	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—APOE—type 2 diabetes mellitus	4.91e-06	5.26e-05	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—PPARA—type 2 diabetes mellitus	4.88e-06	5.22e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	4.87e-06	5.21e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—NOS3—type 2 diabetes mellitus	4.87e-06	5.21e-05	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—APOA1—type 2 diabetes mellitus	4.86e-06	5.2e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	4.85e-06	5.2e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	4.85e-06	5.19e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—NOS3—type 2 diabetes mellitus	4.85e-06	5.19e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—NOS3—type 2 diabetes mellitus	4.8e-06	5.14e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	4.8e-06	5.14e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	4.8e-06	5.14e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	4.8e-06	5.14e-05	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—TGFB1—type 2 diabetes mellitus	4.77e-06	5.11e-05	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—AGT—type 2 diabetes mellitus	4.72e-06	5.06e-05	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—EGFR—type 2 diabetes mellitus	4.68e-06	5.01e-05	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—CALM1—type 2 diabetes mellitus	4.65e-06	4.98e-05	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—APOE—type 2 diabetes mellitus	4.63e-06	4.96e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	4.6e-06	4.93e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	4.6e-06	4.93e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—RELA—type 2 diabetes mellitus	4.58e-06	4.91e-05	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—APOA1—type 2 diabetes mellitus	4.58e-06	4.9e-05	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—TGFB1—type 2 diabetes mellitus	4.57e-06	4.89e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—RELA—type 2 diabetes mellitus	4.57e-06	4.89e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—RELA—type 2 diabetes mellitus	4.52e-06	4.84e-05	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—EGFR—type 2 diabetes mellitus	4.48e-06	4.8e-05	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—PPARG—type 2 diabetes mellitus	4.28e-06	4.58e-05	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—INS—type 2 diabetes mellitus	4.2e-06	4.49e-05	CbGpPWpGaD
Fesoterodine—CHRM1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	4.17e-06	4.47e-05	CbGpPWpGaD
Fesoterodine—CHRM3—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	4.16e-06	4.45e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—CASP3—type 2 diabetes mellitus	4.13e-06	4.42e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—CASP3—type 2 diabetes mellitus	4.12e-06	4.41e-05	CbGpPWpGaD
Fesoterodine—CHRM2—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	4.12e-06	4.41e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling by GPCR—IL6—type 2 diabetes mellitus	4.1e-06	4.4e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling by GPCR—IL6—type 2 diabetes mellitus	4.09e-06	4.38e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—CASP3—type 2 diabetes mellitus	4.08e-06	4.37e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling by GPCR—IL6—type 2 diabetes mellitus	4.05e-06	4.34e-05	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—PPARG—type 2 diabetes mellitus	4.03e-06	4.32e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	3.97e-06	4.25e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.97e-06	4.25e-05	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—INS—type 2 diabetes mellitus	3.95e-06	4.24e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	3.95e-06	4.23e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—MMP9—type 2 diabetes mellitus	3.9e-06	4.18e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	3.9e-06	4.17e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—MMP9—type 2 diabetes mellitus	3.89e-06	4.17e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	3.86e-06	4.14e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—MMP9—type 2 diabetes mellitus	3.85e-06	4.13e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—NFKB1—type 2 diabetes mellitus	3.85e-06	4.12e-05	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—ALB—type 2 diabetes mellitus	3.85e-06	4.12e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	3.81e-06	4.08e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	3.79e-06	4.05e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	3.78e-06	4.05e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling by GPCR—AKT1—type 2 diabetes mellitus	3.77e-06	4.04e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	3.74e-06	4e-05	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—PIK3R1—type 2 diabetes mellitus	3.68e-06	3.94e-05	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—NOS3—type 2 diabetes mellitus	3.68e-06	3.94e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	3.68e-06	3.94e-05	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—ALB—type 2 diabetes mellitus	3.63e-06	3.88e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	3.61e-06	3.87e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—SRC—type 2 diabetes mellitus	3.6e-06	3.85e-05	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—IL6—type 2 diabetes mellitus	3.6e-06	3.85e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—SRC—type 2 diabetes mellitus	3.59e-06	3.84e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—SRC—type 2 diabetes mellitus	3.55e-06	3.81e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	3.53e-06	3.79e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	3.52e-06	3.77e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	3.51e-06	3.75e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—VEGFA—type 2 diabetes mellitus	3.49e-06	3.74e-05	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—PIK3R1—type 2 diabetes mellitus	3.47e-06	3.71e-05	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—NOS3—type 2 diabetes mellitus	3.47e-06	3.71e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	3.46e-06	3.71e-05	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—IL6—type 2 diabetes mellitus	3.44e-06	3.69e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	3.43e-06	3.67e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	3.39e-06	3.63e-05	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—PTGS2—type 2 diabetes mellitus	3.37e-06	3.61e-05	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—AKT1—type 2 diabetes mellitus	3.32e-06	3.55e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	3.25e-06	3.48e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	3.22e-06	3.45e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—TGFB1—type 2 diabetes mellitus	3.21e-06	3.43e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	3.19e-06	3.42e-05	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—AKT1—type 2 diabetes mellitus	3.18e-06	3.4e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	3.18e-06	3.4e-05	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—PTGS2—type 2 diabetes mellitus	3.17e-06	3.4e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—EGFR—type 2 diabetes mellitus	3.15e-06	3.38e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—EGFR—type 2 diabetes mellitus	3.14e-06	3.37e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—EGFR—type 2 diabetes mellitus	3.11e-06	3.34e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	3.09e-06	3.31e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	3.04e-06	3.25e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	3.03e-06	3.24e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	2.99e-06	3.2e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—AKT1—type 2 diabetes mellitus	2.67e-06	2.86e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	2.64e-06	2.82e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	2.59e-06	2.77e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—IL6—type 2 diabetes mellitus	2.42e-06	2.6e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—IL6—type 2 diabetes mellitus	2.42e-06	2.59e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—IL6—type 2 diabetes mellitus	2.39e-06	2.56e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	2.37e-06	2.54e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	2.27e-06	2.43e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	2.27e-06	2.43e-05	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.24e-06	2.4e-05	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.23e-06	2.39e-05	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.21e-06	2.36e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	2.07e-06	2.22e-05	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—AKT1—type 2 diabetes mellitus	1.69e-06	1.81e-05	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—AKT1—type 2 diabetes mellitus	1.59e-06	1.71e-05	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	1.04e-06	1.12e-05	CbGpPWpGaD
